Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Dow
Moodys
Johnson and Johnson
Medtronic

Last Updated: December 4, 2021

DrugPatentWatch Database Preview

Litigation Details for Merck Sharp & Dohme Corp. v. Anchen Pharmaceuticals, Inc. (D. Del. 2019)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in Merck Sharp & Dohme Corp. v. Anchen Pharmaceuticals, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , ⤷  Free Forever Trial , and ⤷  Free Forever Trial .

Details for Merck Sharp & Dohme Corp. v. Anchen Pharmaceuticals, Inc. (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2020-11-16 135 Opinion - Memorandum Opinion terms in U.S. Patent Nos. 7,326,708 (“the ’708 patent”) and 8,414,921 (“the ’921 patent”). The Court … construction for various terms in U.S. Patent Nos. 7,326,708 and 8,414,921. Signed by Judge Richard G…Tr.”]). I. BACKGROUND The ’708 patent and ’921 patent are directed to the dihydrogenphosphate… “It is a bedrock principle of patent law that the claims of a patent define the invention to which …construing patent claims, a court considers the literal language of the claim, the patent specification External link to document
2021-02-18 151 Notice of Service of Claims 1-3, 17, 19 and 21-23 of U.S. Patent No. 7,326,708 filed by Anchen Pharmaceuticals, Inc., Par…2019 2 March 2021 1:19-cv-00311 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2021-03-01 154 Judgment - Consent ii) the term “Licensed Patent” shall mean United States Patent Number 7,326,708; and (iii) the term “…FOR THE DISTRICT OF DELAWARE IN RE: SITAGLIPTIN PATENT LITIGATION MDL No. 19…assigns, is enjoined from infringing the Licensed Patent, on its own part or through any Affiliate, by making…2019 2 March 2021 1:19-cv-00311 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2021-03-01 155 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (Attachments: # 1 …2019 2 March 2021 1:19-cv-00311 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2019-02-12 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (ddp) (Entered: 02…13 February 2019 1:19-cv-00311 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Express Scripts
AstraZeneca
Medtronic
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.